Literature DB >> 21713394

Clinical comparison of dose calculation using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm.

Irina Fotina1, Gabriele Kragl, Bernhard Kroupa, Robert Trausmuth, Dietmar Georg.   

Abstract

PURPOSE: Comparison of the dosimetric accuracy of the enhanced collapsed cone (eCC) algorithm with the commercially available Monte Carlo (MC) dose calculation for complex treatment techniques.
MATERIAL AND METHODS: A total of 8 intensity-modulated radiotherapy (IMRT) and 2 stereotactic body radiotherapy (SBRT) lung cases were calculated with eCC and MC algorithms with the treatment planning systems (TPS) Oncentra MasterPlan 3.2 (Nucletron) and Monaco 2.01 (Elekta/CMS). Fluence optimization as well as sequencing of IMRT plans was primarily performed using Monaco. Dose prediction errors were calculated using MC as reference. The dose-volume histrogram (DVH) analysis was complemented with 2D and 3D gamma evaluation. Both algorithms were compared to measurements using the Delta4 system (Scandidos).
RESULTS: Recalculated with eCC IMRT plans resulted in lower planned target volume (PTV) coverage, as well as in lower organs-at-risk (OAR) doses up to 8%. Small deviations between MC and eCC in PTV dose (1-2%) were detected for IMRT cases, while larger deviations were observed for SBRT (up to 5%). Conformity indices of both calculations were similar; however, the homogeneity of the eCC calculated plans was slightly better. Delta4 measurements confirmed high dosimetric accuracy of both TPS.
CONCLUSION: Mean dose prediction errors < 3% for PTV suggest that both algorithms enable highly accurate dose calculations under clinical conditions. However, users should be aware of slightly underestimated OAR doses using the eCC algorithm.

Entities:  

Mesh:

Year:  2011        PMID: 21713394     DOI: 10.1007/s00066-011-2215-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  24 in total

1.  Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Authors:  Dirk Rades; Cornelia Setter; Juergen Dunst; Olav Dahl; Steven E Schild; Frank Noack
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

2.  Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.

Authors:  Hyunsung Choi; Yang-Sook Chun; Seung-Won Kim; Myung-Suk Kim; Jong-Wan Park
Journal:  Mol Pharmacol       Date:  2006-07-31       Impact factor: 4.436

3.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

Authors:  P Birner; M Schindl; A Obermair; C Plank; G Breitenecker; G Oberhuber
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

4.  Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress.

Authors:  Karina Reyes-Gordillo; José Segovia; Mineko Shibayama; Paula Vergara; Mario G Moreno; Pablo Muriel
Journal:  Biochim Biophys Acta       Date:  2007-02-22

5.  Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway.

Authors:  Daniel P Stiehl; Wolfgang Jelkmann; Roland H Wenger; Thomas Hellwig-Bürgel
Journal:  FEBS Lett       Date:  2002-02-13       Impact factor: 4.124

Review 6.  Chemopreventive and therapeutic effects of curcumin.

Authors:  Annelyse Duvoix; Romain Blasius; Sylvie Delhalle; Michaël Schnekenburger; Franck Morceau; Estelle Henry; Mario Dicato; Marc Diederich
Journal:  Cancer Lett       Date:  2004-11-11       Impact factor: 8.679

7.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Authors:  T Kawamori; R Lubet; V E Steele; G J Kelloff; R B Kaskey; C V Rao; B S Reddy
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

8.  Monitoring of tumor oxygenation changes in head-and-neck carcinoma patients breathing a hyperoxic hypercapnic gas mixture with a noninvasive MRI technique.

Authors:  Markus Kotas; Peter Schmitt; Peter M Jakob; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

9.  Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2.

Authors:  Christine Syng-Ai; A Leela Kumari; Ashok Khar
Journal:  Mol Cancer Ther       Date:  2004-09       Impact factor: 6.261

Review 10.  Regulation of oxygen homeostasis by hypoxia-inducible factor 1.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2009-04
View more
  8 in total

1.  Comparison between Acuros XB and Brainlab Monte Carlo algorithms for photon dose calculation.

Authors:  M Mißlbeck; P Kneschaurek
Journal:  Strahlenther Onkol       Date:  2012-04-12       Impact factor: 3.621

2.  Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.

Authors:  J Koeck; Y Abo-Madyan; H T Eich; F Stieler; J Fleckenstein; J Kriz; R-P Mueller; F Wenz; F Lohr
Journal:  Strahlenther Onkol       Date:  2012-06-29       Impact factor: 3.621

3.  Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms.

Authors:  Wataru Takahashi; Hideomi Yamashita; Naoya Saotome; Yoshio Iwai; Akira Sakumi; Akihiro Haga; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2012-02-09       Impact factor: 3.481

4.  Assessing the role of volumetric-modulated arc therapy in hepatocellular carcinoma.

Authors:  Mian Xi; Li Zhang; Qiao-Qiao Li; Lei Zhao; Rui Zhang; Meng-Zhong Liu
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

5.  Hippocampal-sparing whole-brain radiotherapy using Elekta equipment.

Authors:  Alexander Nevelsky; Nantakan Ieumwananonthachai; Orit Kaidar-Person; Raquel Bar-Deroma; Haitam Nasrallah; Rahamim Ben-Yosef; Abraham Kuten
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

6.  Density scaling of phantom materials for a 3D dose verification system.

Authors:  Kensuke Tani; Yukio Fujita; Akihisa Wakita; Ryohei Miyasaka; Ryuzo Uehara; Takumi Kodama; Yuya Suzuki; Ako Aikawa; Norifumi Mizuno; Jiro Kawamori; Hidetoshi Saitoh
Journal:  J Appl Clin Med Phys       Date:  2018-05-21       Impact factor: 2.102

7.  Dosimetric accuracy of three dose calculation algorithms for radiation therapy of in situ non-small cell lung carcinoma.

Authors:  Manda Švabić Kolacio; David Rajlić; Milan Radojčić; Đeni Smilović Radojčić; Nevena Obajdin; Dea Dundara Debeljuh; Slaven Jurković
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22

8.  Independent absorbed-dose calculation using the Monte Carlo algorithm in volumetric modulated arc therapy.

Authors:  Akihiro Haga; Taiki Magome; Shigeharu Takenaka; Toshikazu Imae; Akira Sakumi; Akihiro Nomoto; Hiroshi Igaki; Kenshiro Shiraishi; Hideomi Yamashita; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2014-03-14       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.